These are the stocks posting the largest moves before the bell.Market Insiderread more
Democrats such as Elizabeth Warren had their eye on business and the working class during the first 2020 presidential primary debate in Miami.2020 Electionsread more
China will demand that the U.S. remove its ban on the sale of U.S. technology to Huawei Technologies, Chinese officials tell the Journal.World Economyread more
Boeing shares fell on Thursday after the FAA said it had found another software issue with the company's grounded 737 Max aircraft.Marketsread more
Earnings estimates are essentially "flattish" for 2019 compared to 2018. This puts stock investors in a difficult position.Trader Talk with Bob Pisaniread more
Here are the biggest calls on Wall Street on ThursdayInvestingread more
As the Dow closes in on records, just four stocks have been shut out of the rally. Some could be on the verge of a major breakout.Trading Nationread more
Bitcoin continues to crater after popular cryptocurrency trading platform Coinbase's outage on Wednesday.Marketsread more
Huawei's legal chief told CNBC that the company makes "solutions for civil use."Technologyread more
The Chinese Ministry of Commerce maintained a firm stance against the U.S. during a weekly press conference on Thursday, less than two days ahead of a scheduled meeting...China Economyread more
The U.S. should not accept a trade deal from China that excludes regulations on Chinese technology giant Huawei, says the hardline former White House chief strategist.Politicsread more
The planned spinoff of General Electric's health unit — GE Healthcare — could be in jeopardy after news that John Flannery was removed as chairman and CEO of the industrial conglomerate, according to one industry analyst.
Jim Corridore, a research equity analyst at CFRA, said Monday that GE's incoming leader, former Danaher CEO Lawrence Culp, could decide that the multibillion-dollar health division would be better off staying within the company.
GE Healthcare, a dominant player in hospital and lab equipment, is a bit of a cash cow, generating roughly $19 billion in revenue and throwing off $3.4 billion in profit last year. It accounted for 15.8 percent of the conglomerate's total sales, and 43.2 percent of its operating profit in 2017.
"Maybe health care is not going to get spun off now," Corridore said in an interview with CNBC's "Power Lunch. " "Maybe some of the parts that were going to be sold make more sense today."
GE Healthcare spokeswoman Jennifer Fox said the unit "plans to continue working toward separation of GE" and news of Flannery's removal "does not change what's happening at GE Healthcare."
And according to GE, the company remains "committed to establishing healthcare as a separate independent entity."
Scott Davis, chairman and CEO of Melius Research in New York, told CNBC that he also doesn't think Flannery's exit changes anything for GE Healthcare. "But I suppose anything is possible," he added.
GE shares were soaring more than 7 percent early Monday afternoon after news that the board removed Flannery from his position.
According to a source familiar with the matter, Flannery's removal was driven by the board's frustration with the slow pace of change under his leadership — not troubles at GE's power business.
Flannery tasked GE Healthcare CEO Kieran Murphy with spinning out the unit into a separate, independent company by the end of 2019. The move made sense for GE, allowing it to double down on its core industrial and energy businesses.
In a recent interview with CNBC, Murphy said he was excited and didn't seem all that worried about the spinoff, calling it "a huge challenge and a great opportunity."